Acrivon Therapeutics, Inc. (ACRV) Free cash flow 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$65.3MFY2025 · since FY2021: -$14.2M → -$65.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.3M | +4.5% |
| FY2024 | -$68.4M | -55.8% |
| FY2023 | -$43.9M | -36.1% |
| FY2022 | -$32.3M | -127.0% |
| FY2021 | -$14.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice